MMSS Keynote: Planning & Executing Effective Clinical Trials for ADRD Research​

Описание: Filmed at our inaugural Mind Matters Science Symposium, this keynote session explores the significance of clinical trials for Alzheimer's disease and
related dementias (ADRD), detailing their progression through various stages.

Listen in as Dr. Holly Massett (NIH/NIA)
and Dr. Tamiko MaGee-Rodgers (Global Alzheimer's Platform) discuss the key
stakeholders involved in trial planning and collaboration, strategies to address R&D challenges
within budget and timelines, the importance of aligning populations with the disease, and effective
recruitment strategies.

🔔 Don't forget to subscribe and hit the bell icon to stay updated with our latest videos! 🔔

📢 Connect with Us:
LabCentral: https://www.labcentral.org/
Instagram: @LabCentral.Inc
LinkedIn: /LabCentral
X: @LabCentral

#MindMattersScienceSymposium #MMSS #LabCentral #NIH #NIA #ClinicalTrials #Neurodegeneration #Alzheimers #Biotech #Startup #Entrepreneur #cambridgema

About the Mind Matters Science Symposium: Backed by Bayer, LabCentral’s first-ever Mind Matters Science Symposium convened top experts to reimagine treatments for neurodegenerative diseases. With panels on clinical trials, preclinical insights, and market trends, the event sparked cross-disciplinary dialogue and collaboration. Speakers from ADDF, BU, Harvard, NIH, and the Picower Institute explored inclusive trial design, emerging disease mechanisms, and the future of investment—reinforcing LabCentral’s role as a catalyst for scientific innovation.